SSA
NSPR icon

Schonfeld Strategic Advisors’s InspireMD NSPR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,334
Closed -$41.5K – 2518
2025
Q4 		$41.5K Sell
23,334
-62,758
-73% -$131K ﹤0.01% 1890
2025
Q3 		$207K Buy
86,092
+48,603
+130% +$118K ﹤0.01% 1938
2025
Q2 		$85.1K Buy
37,489
+3,356
+10% +$8.36K ﹤0.01% 1850
2025
Q1 		$91.8K Buy
34,133
+4,000
+13% +$11.3K ﹤0.01% 2028
2024
Q4 		$79.2K Buy
30,133
+18,233
+153% +$49K ﹤0.01% 1854
2024
Q3 		$31.9K Buy
+11,900
New +$32.5K ﹤0.01% 1903

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Schonfeld Strategic Advisors's NSPR Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of InspireMD (NSPR) in Q1 2026, closing a stake of 23,334 shares — an estimated $41.5K sold.

Schonfeld Strategic Advisors first reported a position in NSPR in Q3 2024 and held it in 6 quarters. The position peaked at $207K in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining InspireMD position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 23,334 InspireMD shares in Q1 2026, an estimated $41.5K.
  • Schonfeld Strategic Advisors first reported a position in InspireMD in Q3 2024 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's InspireMD position peaked at $207K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.